ICI
AVOIDICI Pakistan Limited
Chemicals · 1.16% of the KSE-100
Price
Rs 268.06
Market cap
Rs 218.0bn
12-month return
+5.8%
Rank
96 of 101
Why the engine ranks it here
ICI Pakistan Limited (ICI) screens as one of the least attractive names in the KSE-100, ranking 96 of 101 on a composite score of 32/100.
ICI Pakistan Limited sits in the Chemicals sector and scores best on balance-sheet strength (59/100), weakest on valuation (32/100). At PKR 268.06 the shares trade on a P/E of 3.3x, 0.55x book, a 16.8% dividend yield. The Piotroski F-Score is 7 of 9 (strong) and the Altman Z''-Score is 7.04 (financially sound).
What it does well
ICI holds 2.35x of current assets against current liabilities.
Balance-sheet strength
ICI sits at 0.8x net debt to EBITDA.
Balance-sheet strength
ICI is unusually steady at 24.4% annualised volatility.
Price trend
What holds it back
ICI trades at 0.55x book value, above peers.
Valuation
ICI funds only 32.5% of assets with equity.
Balance-sheet strength
ICI earnings moved 35.1% year on year.
Growth
What would change this view
- → a pull-back in the share price, or earnings catching up with the current multiple
Five-pillar breakdown
Each pillar scores the company against sector peers, where 50 is the sector average.
The classic screens
Piotroski tests nine accounting facts about improvement; Altman scores the distance from financial distress.
Piotroski F-Score
7 / 9
strong · 7 of 9 tests passed
Altman Z''-Score
7.04
safe zone · safe above 5.85
Profitable on assets
ROA 5.6%
Cash generative
CFO PKR 86,163m
Returns improving
ROA 5.6% vs 4.1% a year ago
Earnings backed by cash
CFO PKR 86,163m vs profit PKR 66,190m
Deleveraging
debt/assets 0.20 vs 0.20
Liquidity improving
current ratio 2.35 vs 2.40
Margin expanding
gross margin 29.8% vs 29.0%
Assets working harder
asset turnover 1.04x vs 1.04x
No shareholder dilution
813m shares vs 813m
Altman components
Price history
Weekly closes. Beta 1.01 against the index, annualised volatility 24%, RSI 49.
Reported accounts
The last twelve quarters as filed, in PKR millions. The publication date is what the engine uses to decide when a figure became knowable.
| Quarter | Revenue | Gross profit | Operating | Net income | EPS | Filed |
|---|---|---|---|---|---|---|
| 2025 Q4 | Rs 313.0bn | Rs 88.3bn | Rs 25.7bn | Rs 15.1bn | 18.59 | 2026-04-30 |
| 2025 Q3 | Rs 321.4bn | Rs 98.2bn | Rs 29.5bn | Rs 17.8bn | 21.89 | 2025-11-14 |
| 2025 Q2 | Rs 324.1bn | Rs 74.2bn | Rs 19.6bn | Rs 11.2bn | 13.76 | 2025-08-14 |
| 2025 Q1 | Rs 312.4bn | Rs 99.4bn | Rs 30.3bn | Rs 18.7bn | 23.01 | 2025-05-15 |
| 2024 Q4 | Rs 283.9bn | Rs 98.5bn | Rs 30.9bn | Rs 18.5bn | 22.73 | 2025-04-30 |
| 2024 Q3 | Rs 282.0bn | Rs 84.8bn | Rs 25.3bn | Rs 13.2bn | 16.25 | 2024-11-14 |
| 2024 Q2 | Rs 310.9bn | Rs 94.9bn | Rs 28.5bn | Rs 14.0bn | 17.23 | 2024-08-14 |
| 2024 Q1 | Rs 313.9bn | Rs 88.8bn | Rs 25.9bn | Rs 11.3bn | 13.87 | 2024-05-15 |
| 2023 Q4 | Rs 332.1bn | Rs 91.4bn | Rs 26.4bn | Rs 10.5bn | 12.90 | 2024-04-29 |
| 2023 Q3 | Rs 360.7bn | Rs 90.2bn | Rs 25.0bn | Rs 8.2bn | 10.05 | 2023-11-14 |
| 2023 Q2 | Rs 434.8bn | Rs 92.2bn | Rs 23.3bn | Rs 6.9bn | 8.47 | 2023-08-14 |
| 2023 Q1 | Rs 473.2bn | Rs 77.3bn | Rs 16.0bn | Rs 3.4bn | 4.13 | 2023-05-15 |
Ranked against Chemicals
Every peer in the same sector, ordered by composite score. These are the companies whose ratios set this one's z-scores.
Scored as of 31 December 2025. Generated by an automated screen for research and educational use. Not investment advice, and not a substitute for a SECP-licensed adviser.